Fulgent Genetics (FLGT) Interest Expenses (2023 - 2026)

Fulgent Genetics has reported Interest Expenses for 12 years, with the latest figure at $8.9 million in Q2 2026.

• Quarterly Interest Expenses rose 52341.18% year-over-year to $8.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.9 million (up 6060.4% YoY) and the FY2025 annual result came in at $28.3 million, up 24.87% from the prior year.
• Interest Expenses declined to $8.9 million in Q2 2026 per FLGT's latest filing, from $31.8 million in the prior quarter.
• Over five years, Interest Expenses peaked at $47.6 million in Q3 2022 and troughed at -$632000.0 in Q4 2024.
• A 5-year average of $11.9 million and a median of $8.1 million in 2024 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2024 and 2026: Interest Expenses tumbled 288.66% in 2024, then surged 52341.18% in 2026.
• Over 5 years, Interest Expenses stood at $828000.0 in 2022, then slumped by 59.54% to $335000.0 in 2023, then sank by 288.66% to -$632000.0 in 2024, then soared by 102.53% to $16000.0 in 2025, then jumped by 55406.25% to $8.9 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $8.9 million, $31.8 million, and $16000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.